AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 129 filers reported holding AMPIO PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,000 | -88.5% | 106,412 | -65.6% | 0.00% | – |
| Q2 2022 | $52,000 | +13.0% | 309,724 | +219.8% | 0.00% | – |
| Q1 2022 | $46,000 | -16.4% | 96,844 | -1.9% | 0.00% | – |
| Q4 2021 | $55,000 | -76.8% | 98,681 | -31.3% | 0.00% | – |
| Q3 2021 | $237,000 | +7.7% | 143,631 | +9.1% | 0.00% | – |
| Q2 2021 | $220,000 | -15.4% | 131,598 | -14.4% | 0.00% | – |
| Q1 2021 | $260,000 | +57.6% | 153,737 | +48.9% | 0.00% | – |
| Q4 2020 | $165,000 | +111.5% | 103,231 | +26.3% | 0.00% | – |
| Q3 2020 | $78,000 | +500.0% | 81,751 | +285.3% | 0.00% | – |
| Q2 2020 | $13,000 | +62.5% | 21,219 | +9.7% | 0.00% | – |
| Q1 2020 | $8,000 | -20.0% | 19,338 | +12.8% | 0.00% | – |
| Q4 2019 | $10,000 | -9.1% | 17,147 | -19.4% | 0.00% | – |
| Q3 2019 | $11,000 | -81.0% | 21,280 | -85.8% | 0.00% | – |
| Q2 2019 | $58,000 | +314.3% | 150,025 | +532.1% | 0.00% | – |
| Q1 2019 | $14,000 | -83.5% | 23,734 | -88.9% | 0.00% | – |
| Q4 2018 | $85,000 | -43.7% | 214,783 | -28.2% | 0.00% | – |
| Q3 2018 | $151,000 | -67.8% | 299,120 | +40.0% | 0.00% | – |
| Q2 2018 | $469,000 | -42.7% | 213,597 | -11.3% | 0.00% | – |
| Q1 2018 | $818,000 | +2626.7% | 240,676 | +3217.8% | 0.00% | – |
| Q4 2017 | $30,000 | +900.0% | 7,254 | +51.0% | 0.00% | – |
| Q3 2017 | $3,000 | -93.8% | 4,805 | -94.8% | 0.00% | – |
| Q2 2017 | $48,000 | -57.1% | 93,014 | -33.6% | 0.00% | – |
| Q1 2017 | $112,000 | -58.5% | 140,038 | -53.2% | 0.00% | – |
| Q4 2016 | $270,000 | +2150.0% | 299,072 | +1797.2% | 0.00% | – |
| Q3 2016 | $12,000 | -70.0% | 15,764 | -49.3% | 0.00% | – |
| Q2 2016 | $40,000 | -43.7% | 31,081 | -0.5% | 0.00% | – |
| Q1 2016 | $71,000 | -28.3% | 31,242 | +10.5% | 0.00% | – |
| Q4 2015 | $99,000 | -45.3% | 28,286 | -54.8% | 0.00% | – |
| Q3 2015 | $181,000 | +11.0% | 62,547 | -9.3% | 0.00% | – |
| Q2 2015 | $163,000 | -80.0% | 68,950 | -36.2% | 0.00% | – |
| Q1 2015 | $814,000 | -1.1% | 108,137 | -54.9% | 0.00% | – |
| Q4 2014 | $823,000 | +9.0% | 239,836 | +12.1% | 0.00% | – |
| Q3 2014 | $755,000 | +275.6% | 213,951 | +789.9% | 0.00% | – |
| Q2 2014 | $201,000 | -60.5% | 24,042 | -70.0% | 0.00% | – |
| Q1 2014 | $509,000 | +128.3% | 80,059 | +156.7% | 0.00% | – |
| Q4 2013 | $223,000 | -51.0% | 31,185 | -48.6% | 0.00% | – |
| Q3 2013 | $455,000 | – | 60,715 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|